PTT combined with PD-L1aptamer can trigger cytokines release (Fig. 5G), including macrophage factor (IFN-γ and granzyme B) and proinflammatory factor (TNF-α and IL-6), resulting a strong immune response and tumor growth inhibition (Fig. 5H and I). The gene discussed is IFNG; the disease is neoplasm.